The announcement of clinical results is a significant event for biotech companies like Roivant Sciences. Positive results could lead to increased investor confidence and a potential rise in stock price, while negative results could have the opposite effect. Given that the news is directly about Roivant's upcoming announcements for its drugs, it is highly relevant and important to the company's valuation.